New York, NY, United States of America

Alec W Freyn

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alec W Freyn. Retrieved from https://idiyas.com/inventor/alec-w-freyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alec W Freyn: Innovator in Influenza Vaccine Development

Introduction

Alec W Freyn is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of vaccine development, particularly in the area of influenza.

Latest Patents

Alec W Freyn holds a patent for a "Universal Influenza Vaccine Using Nucleoside-Modified mRNA." This innovative approach aims to enhance the effectiveness of influenza vaccines, potentially providing broader protection against various strains of the virus. He has 1 patent to his name.

Career Highlights

Freyn is affiliated with the University of Pennsylvania, where he conducts research and develops groundbreaking technologies in the field of immunology. His work is pivotal in advancing the understanding and treatment of infectious diseases.

Collaborations

Some of his notable coworkers include Norbert Pardi and Drew Weissman, who are also recognized for their contributions to vaccine research and development.

Conclusion

Alec W Freyn's work in developing a universal influenza vaccine represents a significant advancement in medical science. His innovative approach and collaboration with esteemed colleagues highlight the importance of teamwork in achieving breakthroughs in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…